With annual OCF visibility of $6.0 billion, the company is positioned to deleverage and accelerate investments in the product pipeline.ДЄs cash flows swell further in the coming years, dividend growth seems likely on a sustained basis. With healthy growth in China and other emerging markets, regional diversification implies that the stock is still attractively valued.ДЇor fiscal 2021, AstraZeneca reported an operating cash flow of $4.5 billion. For Q3 2021, the company reported total revenue (excluding Covid-19 vaccine revenue) of $7.5 billion from these markets. With several projects in phases two and three of development, itвЂ™s likely that healthy revenue growth will sustain in the next few years.Д®merging markets are another growth catalyst for the company. The therapeutic areas include oncology, respiratory, immunology, among others.

ItвЂ™s also worth noting that AstraZeneca currently has 175 projects in the pipeline. Robust growth is a key reason to like the company. Excluding the impact of the Covid-19 vaccine, growth was 17%. Besides providing investors with a dividend yield of 1.5%, AZN stock has also trended higher by 14% in the last 12-months.ДЇor Q3 2021, AstraZeneca reported revenue growth of 28% to $25.0 billion. While buying low-beta stocks for the long-term portfolio, AZN is worth considering among the global stocks. Global Stocks to Buy: AstraZeneca (AZN)Д®xterior of the AstraZeneca's manufacturing facility at Snackviken The company, therefore, has ample financial resources for investment in product development and manufacturing expansion. With XPeng likely to enter into more European markets in 2022, deliveries growth will be supported.ДЄs of Q3 2021, XPeng reported cash and equivalents of $7.0 billion. These new models will contribute to delivery growth.ДЇurther, G9 has been designed with a focus on making inroads in the international markets. In the current year, G9 is scheduled for commercial deliveries from Q3 2022. The XPeng P5 was launched in China in September 2021. It seems likely that this growth momentum will sustain in 20.Д§ Best Robinhood Stocks to Buy on the Dip On a year-on-year basis, deliveries were higher by 263%. For 2021, XPeng reported total deliveries of 98,155 vehicles. The company has already been reporting robust vehicle deliveries. By 2024, the company plans to unveil a flying car that can also operate on roads. The electric vehicle industry has multi-year tailwinds and XPeng looks well-positioned to capitalize.ДЇurther, XPeng is making big investments on the innovation front. If I had to choose one Chinese stock in my portfolio of global stocks, it would be XPEV stock. Xpeng logo and P7 model in store XPEV stock

Tsm 4 stor operations globally